These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 30233180)

  • 1. Anti-JNK2 peptide-siRNA nanostructures improve plaque endothelium and reduce thrombotic risk in atherosclerotic mice.
    Pan H; Palekar RU; Hou KK; Bacon J; Yan H; Springer LE; Akk A; Yang L; Miller MJ; Pham CT; Schlesinger PH; Wickline SA
    Int J Nanomedicine; 2018; 13():5187-5205. PubMed ID: 30233180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying progression and regression of thrombotic risk in experimental atherosclerosis.
    Palekar RU; Jallouk AP; Goette MJ; Chen J; Myerson JW; Allen JS; Akk A; Yang L; Tu Y; Miller MJ; Pham CT; Wickline SA; Pan H
    FASEB J; 2015 Jul; 29(7):3100-9. PubMed ID: 25857553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. siRNA-mediated silencing of Wnt5a regulates inflammatory responses in atherosclerosis through the MAPK/NF-κB pathways.
    Yang L; Chu Y; Wang Y; Zhao X; Xu W; Zhang P; Liu X; Dong S; He W; Gao C
    Int J Mol Med; 2014 Oct; 34(4):1147-52. PubMed ID: 25050997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
    Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
    Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predilection of Low Protein C-induced Spontaneous Atherothrombosis for the Right Coronary Sinus in Apolipoprotein E deficient mice.
    Heestermans M; Ouweneel AB; Hassan J; Kloosterman M; Reitsma PH; Gijbels MJJ; van Vlijmen BJM; van Eck M
    Sci Rep; 2018 Oct; 8(1):15106. PubMed ID: 30305662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages.
    Huang X; Liu C; Kong N; Xiao Y; Yurdagul A; Tabas I; Tao W
    Nat Protoc; 2022 Mar; 17(3):748-780. PubMed ID: 35121853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
    Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
    Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
    Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
    Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphA2 Expression Regulates Inflammation and Fibroproliferative Remodeling in Atherosclerosis.
    Finney AC; Funk SD; Green JM; Yurdagul A; Rana MA; Pistorius R; Henry M; Yurochko A; Pattillo CB; Traylor JG; Chen J; Woolard MD; Kevil CG; Orr AW
    Circulation; 2017 Aug; 136(6):566-582. PubMed ID: 28487392
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Fang S; Sun S; Cai H; Zou X; Wang S; Hao X; Wan X; Tian J; Li Z; He Z; Huang W; Liang C; Zhang Z; Yang L; Tian J; Yu B; Sun B
    Theranostics; 2021; 11(19):9358-9375. PubMed ID: 34646375
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological activation of the melanocortin system limits plaque inflammation and ameliorates vascular dysfunction in atherosclerotic mice.
    Rinne P; Silvola JM; Hellberg S; Ståhle M; Liljenbäck H; Salomäki H; Koskinen E; Nuutinen S; Saukko P; Knuuti J; Saraste A; Roivainen A; Savontaus E
    Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1346-54. PubMed ID: 24790139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jnk1 Deficiency in Hematopoietic Cells Suppresses Macrophage Apoptosis and Increases Atherosclerosis in Low-Density Lipoprotein Receptor Null Mice.
    Babaev VR; Yeung M; Erbay E; Ding L; Zhang Y; May JM; Fazio S; Hotamisligil GS; Linton MF
    Arterioscler Thromb Vasc Biol; 2016 Jun; 36(6):1122-31. PubMed ID: 27102962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New role of PCSK9 in atherosclerotic inflammation promotion involving the TLR4/NF-κB pathway.
    Tang ZH; Peng J; Ren Z; Yang J; Li TT; Li TH; Wang Z; Wei DH; Liu LS; Zheng XL; Jiang ZS
    Atherosclerosis; 2017 Jul; 262():113-122. PubMed ID: 28535426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
    Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of junctional adhesion molecule-like protein attenuates atherogenesis and enhances plaque stability in ApoE
    Sun Y; Guan J; Hou Y; Xue F; Huang W; Zhang W; Zhang Y; Zhang C; Yang J
    Clin Sci (Lond); 2019 Jun; 133(11):1215-1228. PubMed ID: 31101724
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-Atherogenic Effects of Vaspin on Human Aortic Smooth Muscle Cell/Macrophage Responses and Hyperlipidemic Mouse Plaque Phenotype.
    Sato K; Shirai R; Yamaguchi M; Yamashita T; Shibata K; Okano T; Mori Y; Matsuyama TA; Ishibashi-Ueda H; Hirano T; Watanabe T
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29891806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis.
    Hueso M; De Ramon L; Navarro E; Ripoll E; Cruzado JM; Grinyo JM; Torras J
    Atherosclerosis; 2016 Dec; 255():80-89. PubMed ID: 27835742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.